Published within
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
...
|
»
»|
| Type |
Product title / description
|
Pub
|
Price |
Report
|
This report aims to explore the opportunities and challenges in the women’s health sector. Market access is evaluated and includes analysis of drug sales, key players, regulatory trends, licensing deals, unmet needs, and marketing strategies.
Published By Datamonitor
|
12 Oct 2011 |
$5700
|
Brief
|
A one stop destination for the latest data and opinion on the US retailer. Aimed at retailers and stakeholders, we analyse Walgreens US business and assess the prospects of its investment in Alliance Boots.
Published By Verdict
|
12 Jul 2012 |
$400
|
Report
|
Overview of the UK pharmaceutical market including socioeconomic and demographic trends, regulatory issues, generics and biosimilars analysis and pharmaceutical company infrastructure analysis.
Published By Datamonitor
|
14 Jun 2010 |
$11400
|
Brief
|
NHS reform is impacting pharmaceutical companies’ interaction with key stakeholders.
Published By Datamonitor
|
25 Mar 2013 |
$500
|
Report
|
This report provides an overview of research and development, manufacturing, outsourcing, and distribution trends, as well as infrastructure profiles for the leading pharmaceutical companies in Turkey.
Published By Datamonitor
|
29 Jun 2011 |
$1900
|
Report
|
This report provides an overview of healthcare expenditure, the insurance and healthcare system, healthcare reforms, drug regulation and intellectual property, and drug pricing and reimbursement in Turkey.
Published By Datamonitor
|
01 Jul 2011 |
$1900
|
Report
|
Overview of the generics and biosimilars landscape including, regulatory issues, drivers and resistors to uptake, level of penetration, and key players operating in the market.
Published By Datamonitor
|
29 Jun 2011 |
$1900
|
Report
|
Datamonitor reports average patient population and prescribing behavior by therapy line in the seven major markets, as well as analysis of therapy switching, patient share by drug class, and class use trends, based on a 199-physician survey.
Published By Datamonitor
|
27 Jul 2011 |
$7600
|
Report
|
Analysis of current treatment dynamics in schizophrenia. The report assesses patient diagnosis rates and uptake rates of approved treatments across the seven major markets using Datamonitor’s primary physician research of 140 psychiatrists.
Published By Datamonitor
|
15 May 2012 |
$7600
|
Report
|
This report provides analysis of current treatment dynamics of rectal cancer. Based on Datamonitor’s survey of 127 oncologists and cancer treaters the report assesses treatment type, prescribing influences, and patient numbers across disease stages.
Published By Datamonitor
|
26 Apr 2012 |
$7600
|
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
...
|
»
»|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.